There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Bone involvement was associated with a significantly elevated risk for brain metastases among female individuals with follicular thyroid cancer. Women with follicular thyroid cancer (FTC) with bone ...

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

The movie adaptation of Tomi Adeyemi's debut YA novel, Children of Blood and Bone, is officially on the horizon. After years in the making, it looks like the literary phenomenon is finally ...

Aside from being approved for bone marrow protection in extensive-stage SCLC, trilaciclib is administered intravenously before chemotherapy, whereas the other 3 are oral drugs given continuously.

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Bone pain. Joint pain ... This study provides a promising pathway to predict metastatic potential earlier, which could enable targeted interventions for patients. Yustein saw osteosarcoma patients ...

Many people living with multiple sclerosis (MS) experience speech issues. With MS, you can develop persistent speech difficulties, or you might have speech problems that come and go. You may find ...

The findings showcase a promising approach to bone healing and tumor control. The work is published in the Journal of Hematology & Oncology. "Through our multidisciplinary effort, we aimed to ...